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Abstract Nanomaterials have been the object of intense
study due to promising applications in a number of different
disciplines. In particular, medicine and biology have seen the
potential of these novel materials with their nanoscale proper-
ties for use in diverse areas such as imaging, sensing and drug
vectorisation. Gold nanoparticles (GNPs) are considered a
very useful platform to create a valid and efficient drug
delivery/carrier system due to their facile and well-studied
synthesis, easy surface functionalization and biocompatibility.
In the present study, stable antibiotic conjugated GNPs were
synthesised by a one-step reaction using a poorly water solu-
ble antibiotic, amoxicillin. Amoxicillin, a member of the
penicillin family, reduces the chloroauric acid to form nano-
particles and at the same time coats them to afford the
functionalised nanomaterial. A range of techniques including
UV–vis spectroscopy, dynamic light scattering (DLS), trans-
mission electron microscopy (TEM) and thermogravimetric
analysis (TGA) were used to ascertain the gold/drug molar
ratio and the optimum temperature for synthesis of uniform
monodisperse particles in the ca. 30–40 nm size range.
Amoxicillin-conjugated gold showed an enhancement of an-
tibacterial activity against Escherichia coli compared to the
antibiotic alone.
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Introduction
Since the discovery of the first antibiotic [1], the scientific
community has spent a great amount of effort in studying,
developing and synthesising new types of antibiotic to fight
bacteria. A large number of antibiotics, divided into various
families having structural or functional similarity, have been
discovered as a result of this intensive research. Unfortunately,
the extensive use of these antibiotics has caused bacteria to
develop new resistance mechanisms including prevention of
drug interaction with the target, efflux of the antibiotic from
the cell and direct destruction or modification of the com-
pound [2, 3]. To win the battle against new strains of bacteria,
an alternative approach may be to use the already well-studied
drug and conjugate it with other entities in order to enhance
anti-microbial activity. In the last decade, nanomaterials have
been widely used in biotechnology [4]. In particular, drug-
conjugated gold nanoparticles (GNPs) have been intensively
investigated as delivery/carrier systems [5–7]. GNPs are
characterised by properties that are potentially suitable for
use in this area. First, gold nanoparticles can be synthesised
in a controlled fashion affording a wide range of sizes
(1–150 nm) [5]. Also, the surface of the gold nanoparticles
can be functionalised through covalent or non-covalent inter-
action without structural modification of the drug [8]. The
conjugation of a drug with the inorganic particles could in-
crease the bio-stability, the bio-distribution and also suppress
some side effects [5–7]. In addition, the high surface area
typical of nanoparticles guarantees a huge drug load; for
example, Zubarev et al. were able to couple ≈70 molecules
of paclitaxel to a GNP of 2 nm [5]. Several examples are
available in the literature of the anti-microbial activity of
antibiotics conjugated with gold nanoparticles [9–11].
Usually, the synthetic pathway starts with the reduction of a
chloroauric acid solution via a range of methods [12–15].
Historically, Turkevich et al. reported [12] the production of
a gold colloid solution using sodium citrate as reducing and
stabilising agent in 1951. In 1973, Frens et al. showed [13] the
possibility of controlling the gold nanoparticle size by chang-
ing the molar ratio of the reagents. In 1994, Brust et al.
proposed [14] a novel method to produce stable gold nano-
particles using a two-phase technique with NaBH4 as the
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reducing agent. In this method, chloroauric acid is transferred
to toluene using tetraoctylammonium bromide as the phase-
transfer reagent and the gold reduced by NaBH4 in the pres-
ence of dodecanethiol. Following the formation of the gold
nanoparticles, their functionalization involves one or more
reaction steps in order to attach the drug to the particle surface.
Various approaches of functionalization have been proposed
in the literature [5–7].
Recently, we reported a simpler water-based approach to
antibiotic-coated gold particles [16] where cefaclor, a sec-
ond generation antibiotic from the cephalosporin family,
was shown to act as a reducing agent to produce the gold
nanoparticles and, at the same time, coat them affording the
desired anti-microbial nanomaterial, all in a single synthe-
sis step. We were able to control the particle size, the
amount of drug loaded and the production time just by
changing reaction temperature. Gold nanoparticles alone
did not show any antibacterial property, and we were able
to show that conjugation between the particles and the drug
was necessary to enhance antibacterial activity against
common gram-positive and gram-negative bacteria com-
pared to cefaclor alone [16]. Moreover, we were able to
coat a functionalised glass slide with cefaclor-reduced gold
nanoparticles creating an antimicrobial film which was very
robust and inhibited the growth of Escherichia coli on the
surface over a range of pH conditions designed to mimic
common cleaning scenarios [16].
Starting from these results, we wanted to investigate the
possibility of using this one-pot synthesis with other drugs,
including antibiotics. The idea was to demonstrate that the
one-step synthesis with cefaclor was not an isolated case, and
that this approach, where the desired drug acts as reducing and
capping agent, can be used to create a wide range of drug-
coated GNPs. We identified various possible drug candidates
that share some features with cefaclor, such as chemical
structure and more importantly, the presence of a primary
amine, which we demonstrated [16] to be at least partly
responsible for the reducing/capping actions in the reaction.
Different molecules from the cephalosporin and penicillin
families, both β-lactam drugs, were investigated, and among
them, amoxicillin, an antibiotic having poor water solubility,
was chosen. Amoxicillin (Fig. 1) is a broad-spectrum β-
lactam antibiotic used to treat bacterial infections of the chest,
urine or ear [17]. Amoxicillin is effective against a range of
bacteria inhibiting the synthesis of the bacterial wall cell, and
it is widely used because it is better adsorbed compared with
other similar antibiotics [17]. Herein, we describe the single-
step synthesis of amoxicillin-coated gold nanoparticles, opti-
mization of the reaction and its antimicrobial activity against
E. coli . Also, we prove that an antibiotic, with very limited
water solubility such as amoxicillin, is suitable for the one-pot




HAuCl4 and amoxicillin were purchased from Sigma-Aldrich
and used as received. Cellulose dialysis tubing (10 kDa) was
purchased from Spectrum Laboratory Inc. and the membrane
prepared for use by removing any glycerine and preservative
according to the manufacturers procedure. E. coli culture
(K12) was used for the antibacterial study.
Synthesis and characterization of amoxicillin-coated gold
nanoparticles
Aqueous solutions of amoxicillin (0.01 (not fully solubilised),
0.001 M) and HAuCl4 (0.01 M) were prepared for use in the
one-pot synthesis according to our previous work [16].
Materials were prepared at a range of gold/antibiotic molar
ratios and temperatures (20–70 °C). An example preparation
(as for the material used for antimicrobial activity testing) is as
follows: 9.65mL of dd. H2O, 100μL of HAuCl4 (0.01M) and
250 μL of amoxicillin (0.001M)were mixed and the resulting
solution heated in a water bath at 40 °C for 4 h. Freshly
synthesised amoxicillin-coated gold nanoparticles were
dialysed using a 10 kDa cut-off cellulose membrane against
double-distilled water for 24 h to remove any unreacted
chemicals. Once dialysed, the samples were freeze-dried at
223 K using a VirTis freeze dryer.
The shape and size of the gold nanoparticles was deter-
mined by transmission electron microscopy (TEM) (JEOL
2010; accelerating voltage of 200 kV). TEM samples were
prepared by depositing a 10 μl drop of drug-coated gold
nanoparticle solution on a carbon-coated grid (Quantifoil
grids: Cu 200 mesh). Samples were air-dried for 5–10 min
and excess solution removed using a tissue paper before being
left to dry at room temperature overnight. One hundred parti-
cles were measured and their average size computed. The size
and the charge carried by the gold and gold/antibiotic nano-
particles in solution was also determined by dynamic light
scattering/zeta potential measurement (DLS) using a Malvern
Instrument Nano-S.
The antibiotic ‘load’ of the nanoparticles was determined
using thermogravimetric analysis (TGA) using a Mettler–
Toledo (TGA/SDTA851) instrument. Samples were heated
in air over a temperature range of 30–900 °C, at 10 °C/min.
Antimicrobial activity testing
E. coli was grown in lysogeny broth (LB) for 24 h at 37 °C
and cell counts were quantified by OD590 measurement.
Amox–GNPs solutions were added to E. coli suspensions,
incubated and shaken at 37 °C prior to dilution, plating and
incubation on LB Agar plates. Antibacterial activity was
104 Gold Bull (2014) 47:103–107
determined by plotting colony-forming units against incuba-
tion times 0, 2 and 4 h. For each experiment, three different
Amox–GNPs solutions were added to a suspension of bacteria
(100, 200 and 300 μg/mL), which corresponded to 33, 66 and
99 μg/mL of amoxicillin present on the GNPs, respectively.
Also, a solution containing amoxicillin alone (150 μg/mL)
was prepared as a control to compare the antibacterial behav-
iour. The microbiology experiments were performed in
triplicate.
Colony counting was performed using a Synbiosis
aCOLyte (7510/SYN) colony counter. The minimum inhibi-
tion concentration was calculated according to the method
used by Sambhy et al. [18]
Results and discussion
Amoxicillin-coated gold nanoparticles were prepared accord-
ing to the one-pot synthesis of cefaclor–GNPs presented in
our previous work [16]. In this case, the molar ratio of the
reagents was varied, in part due to the lower water solubility of
amoxicillin. A complete UV–vis study was carried out in
order to establish the best reaction conditions to achieve the
coated gold nanoparticles. Three properties (peak position,
peak breadth and peak intensity) of the UV–vis spectrumwere
used. The surface plasmon resonance (SPR) band typical of
the gold nanoparticles lies in the visible region of the electro-
magnetic spectrum with any changes to the surroundings of
these particles, such as surface modification and aggregation,
leading to a colorimetric change of the dispersion. Thus, the
SPR peak position provides information about the particle size
and the broadness of the SPR absorption peak information on
particle size distribution, a broad band signifying a broad
particle size distribution and aggregation. Finally, the absorp-
tion value is proportional to the amount of gold nanoparticles
produced [19, 20]. Figure 2a shows the UV–vis spectra of
amoxicillin–GNPs samples produced using four different mo-
lar ratios of Au(III)/amoxicillin. The best result was obtained
with a molar ratio of 4:1 as confirmed by a sharp peak in
Fig. 2a. Our previous work [16] showed the importance of
temperature on the one-pot synthesis, where for cefaclor in-
creasing reaction temperature led to a decrease in reaction
Fig. 1 Chemical structure of amoxicillin
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Fig. 2 a UV–vis spectra of amoxicillin-coated gold nanoparticles ob-
tained at different molar ratios of Au(III) and amoxicillin. b UV–vis
spectra of amoxicillin-coated gold nanoparticles synthesised at different
temperatures (gold: antibiotic molar ratio of 4:1). c TGA analyses of
amoxicillin-coated gold nanoparticles synthesised at different tempera-
tures with the same molar ratio as in 1b. Amoxicillin (1), amoxicillin–
GNPs at 20 °C (2), 30 °C (3), 40 °C (4), 50 °C (5), 60 °C (6) and 70 °C (7)
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time, a linear decrease in particle size and decrease in amount
of drug loaded on the nanoparticles [16]. In the current study, a
linear dependence of particle size with temperature was not
seen; rather, the UV–vis spectra of the resulting gold colloid
solutions presented in Fig. 2b show that temperature largely
affected the growth and aggregation of the particles with the
best (least aggregated/more uniform in size) particles being
obtained at 40 °C.
With the optimum synthesis conditions, an aqueous solu-
tion of amoxicillin and chloroauric acid (1:4) heated at 40 °C
in a water bath for 4 h gave the typical red wine colour of a
gold colloid solution. The UV–vis absorption spectrum in
Fig. 3 shows the characteristic SPR band with the maximum
peak at 540 nm. The sharp absorption band is evidence of a
fine nanoparticle dispersion without aggregation and precipi-
tation (flocculation). Zeta potential measurements performed
on the same sample confirmed the stability of the negatively
charged amoxicillin-coated gold nanoparticles with a value
of −31.3 mV. TEM analysis (Fig. 4) confirmed the uniform
size and particle distribution with an average spherical di-
ameter of 32.61±4.78 nm. The lighter areas surrounding the
ca. 30 nm gold–antibiotic nanoparticles also contain gold in
the form of much smaller nanoparticles of the order of
1–2 nm in diameter, also associated with organic material
(antibiotic) that are not discernible separately in the images
shown. DLS analysis corroborated this finding with a mea-
sured particle size of 37.85±13.20 nm, Fig. 3 inset. The
amount of antibiotic bound to the particles as measured by
TGA, Fig. 2c, was around 33 % by weight.
Fig. 3 UV–vis spectrum of amoxicillin-conjugated gold nanoparticles
synthesised at 40 °C. Histogram of size distribution (inset bottom left) and
zeta-potential measurement (inset top right) of the amoxicillin-conjugat-
ed gold nanoparticles obtained at 40 °C for the 4:1 gold : antibiotic sample
a b
Fig. 4 TEM images of the coated gold nanoparticles synthesised at a 4:1 M ratio of gold: antibiotic at 40 °C recorded at different magnifications. Scale
bar in TEM images is 500 (a) and 100 nm (b)
Fig. 5 Histogram plot showing antimicrobial activity of amoxicillin-
conjugated gold nanoparticles (synthesis as per Fig. 2) and amoxicillin
on E. coli after different incubation times (0, 2, and 4 h). All concentra-
tions are in units of μg/ml. The ‘blank’without addition of amoxicillin or
amoxicillin-conjugated gold nanoparticles is shown for t=0 only where it
was possible to measure the colony forming units
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The antimicrobial activity of the antibiotic-coated
nanoparticles was determined against a common gram-
negative bacteria E. coli . Heating to 40 °C during the
formation of the antibiotic loaded particles did not affect
the antibacterial capability of the amoxicillin present on
the gold nanoparticles.
Figure 5 showed that the lowest concentration sample
Amox–GNPs 100 μg/mL did not inhibit the growth of E.
coli colonies over 4 h of incubation at 37 °C. The
presence of 33 μg/mL of amoxicillin associated with
the gold particles was enough to slow down the growth
of the gram-negative bacteria. The Amox–GNPs 200 μg/
mL sample killed half of the E. coli colonies in 2 h of
incubation, and after 4 h, only 2 % of the number was
observed. The 300 μg/mL Amox–GNPs (99 μg/mL of
amoxicillin) sample killed 99 % of the bacteria in 2 h,
showing the same antibacterial activity compared to
amoxicillin alone when the antibiotic alone was used at
a higher concentration (150 μg/mL). The conjugation of
the drug with gold nanoparticles enhanced the antimicro-
bial activity of the antibiotic. The minimum time re-
quired to inhibit the complete growth of E. coli was
2 h, and the minimum inhibition concentration of gram-
negative bacteria obtained from the amoxicillin-reduced
gold nanoparticles was determined according to the
method of Sambhy et al. [18] as 300 μg/mL (99 μg/
mL of amoxicillin).
Conclusions
In summary, we describe an easy way to produce
antibiotic-coated gold nanoparticles using a single reac-
tion step where the amoxicillin reduced the gold ions and
capped the resulting gold nanoparticles. We show that this
particular synthetic pathway can be used with antibiotics
that are poorly soluble in aqueous solution and that prep-
aration of the gold-coated particles at temperatures above
body temperature for extended times does not destroy the
activity of the antibiotic. The conjugation of amoxicillin
with gold nanoparticles enhances antibacterial activity as
the same microbiological activity is achieved with ca.
33 % less amoxicillin. Currently, we are investigating
the possibility to use this one-pot synthesis to coat gold
nanoparticles with other families of antibiotics and/or
drugs, which must display a primary amine group, but also
have enough reducing power to generate gold nanoparticles.
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